跳至主要内容
临床试验/NCT02935530
NCT02935530已完成3 期

Effectiveness and Safety of Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Huazhong University of Science and Technology1 个研究点 分布在 1 个国家目标入组 315 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
315
试验地点
1
主要终点
VTE rate

研究概览

简要总结

Venous thromboembolism (VTE) is an important cause of post-operative morbidity and mortality in women undergoing surgery for gynecologic malignancies. Although the benefit of thromboprophylaxis in reduction of post-operative VTE events after surgery for gynecologic cancers has been well documented around the world, the evidence for Chinese women is rare. The investigators designed this prospective and randomized study to assess the benefit of pharmacologic prophylaxis for patients received surgical treatment for gynecologic malignancies in China.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 70 Years(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients of ovarian cancer, cervix cancer or endometrial cancer;
  • Age ≤ 70 years; female, Chinese women;
  • Initial treatment is surgery;
  • Laboratory tests: WBC ≥ 4×10(9)/L, NEU ≥ 2×10(9)/L, PLT ≥ 100×10(9)/L, serum bilirubin ≤ 1.5 times the upper limit of normal, transaminase ≤ 1.5 times the upper limit of normal, BUN, Cr ≤ normal
  • No prior pharmacologic prophylaxis;
  • Provide written informed consent.

排除标准

  • PLT ≤ 75×10(9)/L
  • Vascular injury
  • History of thrombosis
  • Liver and kidney dysfunction
  • Concurrently participating in other clinical trials
  • Unable or unwilling to sign informed consents;
  • Unable or unwilling to abide by protocol.

研究组 & 干预措施

s-LMWH

Experimental

2125 I.U. subcutaneous injection for 5-10 days

干预措施: s-LMWH (Drug)

LMWH

Active Comparator

4250 I.U. subcutaneous injection for 5-10 days

干预措施: LMWH (Drug)

Argatroban

Experimental

20mg, injection for 5-10 days

干预措施: Argatroban (Drug)

结局指标

主要结局

VTE rate

时间窗: 30-days from the date of operation

次要结局

  • Infection rate(30-days from the date of operation)
  • Bleeding rate(30-days from the date of operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ding Ma

Director of the department of Obstetrics and Gynecology, Tongji Hospital

Huazhong University of Science and Technology

研究点 (1)

Loading locations...

相似试验